Fulcrum Therapeutics, Inc. FULC Q4 2025 Annual earnings

FAQ

When did Fulcrum Therapeutics, Inc. report Q4 2025 earnings?

Fulcrum Therapeutics, Inc. (FULC) reported Q4 2025 earnings on February 24, 2026 before market open.

What were Fulcrum Therapeutics, Inc.'s Q4 2025 revenue and EPS?

Fulcrum Therapeutics, Inc. reported eps of $-0.31 for Q4 2025.

Did Fulcrum Therapeutics, Inc. beat estimates in Q4 2025?

EPS beat the consensus estimate of $-0.31 by $0.00.

How did Fulcrum Therapeutics, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 0.0% from $-0.31.

Where can I find Fulcrum Therapeutics, Inc.'s Q4 2025 SEC filings?

You can read the 8-K earnings release (0001193125-26-065190) and the 10-K periodic report (0001193125-26-065197) directly on SEC EDGAR. The filing index links above go to sec.gov.